ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

In Brief: Oncology Nursing Society Names Board Of Directors

May 16, 2014

House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.

July 1, 2005

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988